GH logo

GH
Guardant Health Inc

4,874
Mkt Cap
$13.12B
Volume
1.51M
52W High
$112.43
52W Low
$29.91
PE Ratio
-31.77
GH Fundamentals
Price
$102.07
Prev Close
$101.38
Open
$103.52
50D MA
$87.82
Beta
1.41
Avg. Volume
3.05M
EPS (Annual)
-$3.56
P/B
-36.00
Rev/Employee
$365,668.48
Loading...
Loading...
News
all
press releases
Eventide Asset Management LLC Sells 107,775 Shares of Guardant Health, Inc. $GH
Eventide Asset Management LLC lowered its position in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 3.0% in the second quarter, according to the company in its most recent filing with...
MarketBeat·2h ago
News Placeholder
More News
News Placeholder
Osterweis Capital Management Inc. Lowers Stock Position in Guardant Health, Inc. $GH
Osterweis Capital Management Inc. cut its holdings in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 19.0% during the second quarter, according to the company in its most recent filing...
MarketBeat·1d ago
News Placeholder
Guardant Health (NASDAQ:GH) Director Sells $131,250.00 in Stock
Guardant Health, Inc. (NASDAQ:GH - Get Free Report) Director Medina Manuel Hidalgo sold 1,250 shares of the business's stock in a transaction on Monday, December 8th. The shares were sold at an...
MarketBeat·1d ago
News Placeholder
Darya Chudova Sells 13,664 Shares of Guardant Health (NASDAQ:GH) Stock
Guardant Health, Inc. (NASDAQ:GH - Get Free Report) CTO Darya Chudova sold 13,664 shares of the business's stock in a transaction that occurred on Monday, December 8th. The shares were sold at an...
MarketBeat·1d ago
News Placeholder
Insider Selling: Guardant Health (NASDAQ:GH) CEO Sells 100,000 Shares of Stock
Guardant Health, Inc. (NASDAQ:GH - Get Free Report) CEO Amirali Talasaz sold 100,000 shares of the firm's stock in a transaction dated Monday, December 8th. The shares were sold at an average price...
MarketBeat·1d ago
News Placeholder
Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S.
Guardant Health (Nasdaq: GH), a leading precision oncology company, and Trial Library, an AI technology company enabling oncology clinical trials as a care option, today announced a strategic...
Business Wire·2d ago
News Placeholder
HighVista Strategies LLC Has $1.47 Million Stake in Guardant Health, Inc. $GH
HighVista Strategies LLC reduced its stake in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 45.3% in the 2nd quarter, according to its most recent 13F filing with the Securities and...
MarketBeat·2d ago
News Placeholder
Guardant Health (NASDAQ:GH) CEO Amirali Talasaz Sells 100,000 Shares
Guardant Health, Inc. (NASDAQ:GH - Get Free Report) CEO Amirali Talasaz sold 100,000 shares of the stock in a transaction that occurred on Monday, December 8th. The stock was sold at an average price...
MarketBeat·2d ago
News Placeholder
Is Tempus AI Stock a Buy Now or a Hold After a Big 2025 Run?
Tempus AI rallies in 2025, but a Hold rank and mixed style scores argue for patience until pricing, FDA, and MRD milestones firm up.
Zacks·4d ago
News Placeholder
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna Purchases New Holdings in Guardant Health, Inc. $GH
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna acquired a new position in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) during the 2nd quarter, according to its most recent...
MarketBeat·4d ago

Latest GH News

View

Advertisement|Remove ads.

Advertisement|Remove ads.